CHILDRESS CAPITAL ADVISORS, LLC

Position in EXEL — Exelixis, Inc.

CIK 1849561 HOUSTON, TX

Position in EXEL

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$269,057

+$63,185 QoQ

Shares Held

4,945

+3.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#538

of 751 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

CHILDRESS CAPITAL ADVISORS, LLC holds $906,617 across 3 Biotechnology names. EXEL ranks #3 (29.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	523	$326,111
2	VRTX	Vertex Pharmaceuticals Inc / Ma	627	$311,449
3	EXEL	Exelixis, Inc. This page	4,945	$269,057

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$269,057	4,945	+3.0%	Shares	Sole	2026-07-27
2026-03-31	$205,872	4,800	—	Shares	Sole	2026-04-29
No filing history on record for this holder in this stock.